Annual Net Income
-$29.73 M
-$39.07 M-417.95%
31 December 2023
Summary:
Arcturus Therapeutics Holdings annual net profit is currently -$29.73 million, with the most recent change of -$39.07 million (-417.95%) on 31 December 2023. During the last 3 years, it has risen by +$42.42 million (+58.80%). ARCT annual net income is now -417.95% below its all-time high of $9.35 million, reached on 31 December 2022.ARCT Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$6.90 M
+$10.31 M+59.90%
30 September 2024
Summary:
Arcturus Therapeutics Holdings quarterly net profit is currently -$6.90 million, with the most recent change of +$10.31 million (+59.90%) on 30 September 2024. Over the past year, it has increased by +$9.32 million (+57.45%). ARCT quarterly net income is now -105.88% below its all-time high of $117.35 million, reached on 31 December 2022.ARCT Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$62.64 M
+$9.32 M+12.95%
30 September 2024
Summary:
Arcturus Therapeutics Holdings TTM net profit is currently -$62.64 million, with the most recent change of +$9.32 million (+12.95%) on 30 September 2024. Over the past year, it has dropped by -$161.97 million (-163.07%). ARCT TTM net income is now -156.30% below its all-time high of $111.27 million, reached on 31 March 2023.ARCT TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARCT Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -417.9% | +57.5% | -163.1% |
| 3 y3 years | +58.8% | +87.2% | +68.1% |
| 5 y5 years | -36.5% | +7.1% | -291.2% |
ARCT Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -417.9% | +85.4% | -105.9% | +87.2% | -156.3% | +69.2% |
| 5 y | 5 years | -417.9% | +85.4% | -105.9% | +87.8% | -156.3% | +69.2% |
| alltime | all time | -417.9% | +85.4% | -105.9% | +87.8% | -156.3% | +69.2% |
Arcturus Therapeutics Holdings Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$6.90 M(-59.9%) | -$62.64 M(-12.9%) |
| June 2024 | - | -$17.22 M(-35.8%) | -$71.96 M(-32.9%) |
| Mar 2024 | - | -$26.82 M(+129.1%) | -$107.30 M(+261.0%) |
| Dec 2023 | -$29.73 M(-417.9%) | -$11.71 M(-27.8%) | -$29.73 M(-129.9%) |
| Sept 2023 | - | -$16.22 M(-69.1%) | $99.33 M(+23.7%) |
| June 2023 | - | -$52.55 M(-203.5%) | $80.28 M(-27.8%) |
| Mar 2023 | - | $50.75 M(-56.7%) | $111.27 M(+1090.2%) |
| Dec 2022 | $9.35 M(-104.6%) | $117.35 M(-432.7%) | $9.35 M(-106.4%) |
| Sept 2022 | - | -$35.27 M(+63.5%) | -$146.66 M(-11.4%) |
| June 2022 | - | -$21.56 M(-57.9%) | -$165.48 M(-16.6%) |
| Mar 2022 | - | -$51.17 M(+32.3%) | -$198.50 M(-2.5%) |
| Dec 2021 | -$203.67 M(+182.3%) | -$38.66 M(-28.5%) | -$203.67 M(+3.9%) |
| Sept 2021 | - | -$54.08 M(-0.9%) | -$196.12 M(+20.3%) |
| June 2021 | - | -$54.58 M(-3.1%) | -$163.03 M(+37.3%) |
| Mar 2021 | - | -$56.35 M(+81.2%) | -$118.72 M(+64.5%) |
| Dec 2020 | -$72.15 M(+177.6%) | -$31.10 M(+48.1%) | -$72.15 M(+38.7%) |
| Sept 2020 | - | -$21.00 M(+104.7%) | -$52.03 M(+35.3%) |
| June 2020 | - | -$10.26 M(+5.0%) | -$38.46 M(+33.2%) |
| Mar 2020 | - | -$9.78 M(-11.0%) | -$28.88 M(+11.1%) |
| Dec 2019 | -$25.99 M(+19.3%) | -$10.99 M(+47.8%) | -$25.99 M(+62.3%) |
| Sept 2019 | - | -$7.43 M(+985.1%) | -$16.01 M(+24.8%) |
| June 2019 | - | -$685.00 K(-90.0%) | -$12.83 M(-41.9%) |
| Mar 2019 | - | -$6.88 M(+580.9%) | -$22.10 M(+1.4%) |
| Dec 2018 | -$21.79 M | -$1.01 M(-76.2%) | -$21.79 M(-16.4%) |
| Sept 2018 | - | -$4.25 M(-57.3%) | -$26.05 M(+4.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | -$9.95 M(+51.4%) | -$24.98 M(+54.9%) |
| Mar 2018 | - | -$6.57 M(+24.5%) | -$16.13 M(+23.3%) |
| Dec 2017 | -$10.90 M(+594.0%) | -$5.28 M(+66.2%) | -$13.08 M(-240.5%) |
| Sept 2017 | - | -$3.18 M(+189.1%) | $9.31 M(+98.7%) |
| June 2017 | - | -$1.10 M(-68.8%) | $4.68 M(<-9900.0%) |
| Mar 2017 | - | -$3.52 M(-120.6%) | -$5000.00(-99.7%) |
| Dec 2016 | -$1.57 M(-17.4%) | $17.11 M(-319.2%) | -$1.57 M(-73.9%) |
| Sept 2016 | - | -$7.80 M(+34.8%) | -$6.02 M(+143.0%) |
| June 2016 | - | -$5.79 M(+13.8%) | -$2.48 M(+36.7%) |
| Mar 2016 | - | -$5.09 M(-140.2%) | -$1.81 M(-4.8%) |
| Dec 2015 | -$1.90 M(-94.2%) | $12.66 M(-397.0%) | -$1.90 M(-91.1%) |
| Sept 2015 | - | -$4.26 M(-16.8%) | -$21.36 M(-22.6%) |
| June 2015 | - | -$5.12 M(-1.0%) | -$27.59 M(-8.8%) |
| Mar 2015 | - | -$5.18 M(-23.9%) | -$30.25 M(-7.9%) |
| Dec 2014 | -$32.83 M(+211.3%) | -$6.80 M(-35.1%) | -$32.83 M(+3.5%) |
| Sept 2014 | - | -$10.49 M(+34.8%) | -$31.74 M(+30.2%) |
| June 2014 | - | -$7.78 M(+0.2%) | -$24.38 M(+35.9%) |
| Mar 2014 | - | -$7.77 M(+36.2%) | -$17.94 M(+70.1%) |
| Dec 2013 | -$10.55 M(+568.0%) | -$5.70 M(+82.4%) | -$10.55 M(+105.3%) |
| Sept 2013 | - | -$3.13 M(+133.6%) | -$5.14 M(+124.0%) |
| June 2013 | - | -$1.34 M(+255.2%) | -$2.29 M(+64.4%) |
| Mar 2013 | - | -$377.00 K(+27.8%) | -$1.40 M(+37.0%) |
| Dec 2012 | -$1.58 M(-59.8%) | -$295.00 K(+4.2%) | -$1.02 M(+40.8%) |
| Sept 2012 | - | -$283.00 K(-35.7%) | -$723.00 K(+64.3%) |
| June 2012 | - | -$440.00 K | -$440.00 K |
| Dec 2011 | -$3.93 M | - | - |
FAQ
- What is Arcturus Therapeutics Holdings annual net profit?
- What is the all time high annual net income for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings annual net income year-on-year change?
- What is Arcturus Therapeutics Holdings quarterly net profit?
- What is the all time high quarterly net income for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings quarterly net income year-on-year change?
- What is Arcturus Therapeutics Holdings TTM net profit?
- What is the all time high TTM net income for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings TTM net income year-on-year change?
What is Arcturus Therapeutics Holdings annual net profit?
The current annual net income of ARCT is -$29.73 M
What is the all time high annual net income for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high annual net profit is $9.35 M
What is Arcturus Therapeutics Holdings annual net income year-on-year change?
Over the past year, ARCT annual net profit has changed by -$39.07 M (-417.95%)
What is Arcturus Therapeutics Holdings quarterly net profit?
The current quarterly net income of ARCT is -$6.90 M
What is the all time high quarterly net income for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high quarterly net profit is $117.35 M
What is Arcturus Therapeutics Holdings quarterly net income year-on-year change?
Over the past year, ARCT quarterly net profit has changed by +$9.32 M (+57.45%)
What is Arcturus Therapeutics Holdings TTM net profit?
The current TTM net income of ARCT is -$62.64 M
What is the all time high TTM net income for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high TTM net profit is $111.27 M
What is Arcturus Therapeutics Holdings TTM net income year-on-year change?
Over the past year, ARCT TTM net profit has changed by -$161.97 M (-163.07%)